ArticleInternational journal of clinical oncology2021

A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

Taiga Otsuka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.